Matthew Hamilton Rosenberg’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Matthew Hamilton Rosenberg's LLY Position: Q2 2026 in Review
Matthew Hamilton Rosenberg increased its Eli Lilly (LLY) stake by 15% in Q2 2026, buying an estimated $100K and bringing the position to 748 shares worth $897K. The position accounts for 0.17% of the portfolio, ranked #63.
Matthew Hamilton Rosenberg first reported a position in LLY in Q1 2020 and has held it in 26 quarters since. 4,601 funds tracked by Wall St. Rank hold LLY as of Q2 2026.
- Matthew Hamilton Rosenberg held 748 shares of Eli Lilly worth $897K as of Q2 2026.
- Matthew Hamilton Rosenberg bought 98 Eli Lilly shares in Q2 2026, an estimated $100K.
- Eli Lilly made up 0.17% of Matthew Hamilton Rosenberg's portfolio in Q2 2026, its #63 holding.
- Matthew Hamilton Rosenberg first reported a position in Eli Lilly in Q1 2020 and has held it in 26 quarters since.
- 4,601 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.
Based on Matthew Hamilton Rosenberg's 13F filing for Q2 2026, filed 17 Jul 2026.